ArticleScientific reports2026

The E3 ubiquitin ligase RNF180 modulates the EGFR/PI3K/AKT pathway to reduce cisplatin resistance in non-small cell lung cancer.

Xiaoyan Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.